Menu

Question 861

Topic: Biology, Genetics & Bone Healing

Lubricin (PRG4) is a critical glycoprotein responsible for boundary lubrication in human articular joints. Which cells are the primary producers of lubricin within the joint environment?

. Synovial fibroblasts and superficial zone chondrocytes
. Middle zone chondrocytes
. Deep zone chondrocytes
. Calcified zone chondrocytes
. Subchondral osteoblasts

Correct Answer & Explanation

. Synovial fibroblasts and superficial zone chondrocytes


Explanation

Lubricin is primarily synthesized by synovial fibroblasts and chondrocytes in the superficial zone of articular cartilage. It localizes to the cartilage surface and provides boundary lubrication, which reduces friction during joint motion and protects the articular surface from wear.

Question 862

Topic: Biology, Genetics & Bone Healing

During the process of endochondral ossification, growth plate chondrocytes undergo a period of hypertrophy before programmed cell death and subsequent vascular invasion. Which of the following collagen types is predominantly and specifically synthesized by these hypertrophic chondrocytes to facilitate matrix mineralization?

. Type I
. Type II
. Type IX
. Type X
. Type XI

Correct Answer & Explanation

. Type X


Explanation

Type X collagen is the specific biochemical marker for hypertrophic chondrocytes in the growth plate during endochondral ossification. It is essential for tissue calcification and matrix degradation, preparing the scaffold for vascular invasion and subsequent replacement by primary woven bone (which is predominantly Type I collagen).

Question 863

Topic: Biology, Genetics & Bone Healing

A 24-year-old woman presents with worsening knee pain. Radiographs reveal an eccentric, lytic epiphyseal lesion extending to the subchondral bone of the distal femur. Biopsy reveals neoplastic mononuclear cells interspersed with numerous reactive multinucleated giant cells. If the tumor is deemed surgically unresectable, medical management with Denosumab is indicated. What is the precise molecular target of this medication?

. Osteoclast proton pumps
. RANK Ligand (RANKL)
. CD20 surface antigen
. Tyrosine kinase c-KIT
. Vascular Endothelial Growth Factor (VEGF)

Correct Answer & Explanation

. RANK Ligand (RANKL)


Explanation

Denosumab is an FDA-approved monoclonal antibody used to treat Giant Cell Tumor (GCT) of bone. Its specific target is RANK Ligand (RANKL). In GCTs, the neoplastic mononuclear cells overexpress RANKL, which aggressively recruits and activates the reactive multinucleated giant cells (which are osteoclast-like) that cause the massive bone destruction seen in the disease. Blocking RANKL halts this destructive osteolytic process.

Question 864

Topic: Biology, Genetics & Bone Healing
Romosozumab is a recently FDA-approved, highly effective anabolic agent for the treatment of severe osteoporosis. It promotes massive increases in bone mineral density by binding to and inhibiting which of the following molecular targets, thereby upregulating the Wnt/β-catenin signaling pathway in osteoblasts?
. Receptor Activator of Nuclear factor Kappa-B Ligand (RANKL)
. Sclerostin
. Cathepsin K
. Osteoprotegerin (OPG)
. Parathyroid hormone-related protein (PTHrP)

Correct Answer & Explanation

. Sclerostin


Explanation

Romosozumab is a monoclonal antibody that targets and inhibits sclerostin. Sclerostin, naturally produced by osteocytes, acts as a brake on bone formation by inhibiting the Wnt/β-catenin signaling pathway in osteoblasts. By blocking sclerostin, romosozumab removes this inhibition, resulting in a potent anabolic effect with rapid bone formation, alongside a mild anti-resorptive effect.

Question 865

Topic: Biology, Genetics & Bone Healing

Bone morphogenetic proteins (BMPs) initiate osteogenesis by binding to serine-threonine kinase receptors. Which intracellular signaling molecules are directly phosphorylated by the BMP receptor complex and subsequently translocate to the nucleus to regulate gene expression?

. Smad 1, 5, and 8
. Smad 2 and 3
. Smad 4
. Smad 6 and 7
. Beta-catenin

Correct Answer & Explanation

. Smad 1, 5, and 8


Explanation

BMP signaling is mediated by receptor-regulated Smads 1, 5, and 8. TGF-beta and Activin signal through Smads 2 and 3. Smad 4 is a common co-Smad that binds to these activated R-Smads for nuclear translocation. Smads 6 and 7 are inhibitory.

Question 866

Topic: Biology, Genetics & Bone Healing

A 32-year-old female presents with a lytic, eccentrically located epiphyseal lesion in the proximal tibia. Biopsy reveals mononuclear cells and multinucleated giant cells. Which of the following is the true neoplastic cell component and its characteristic receptor expression?

. Multinucleated giant cells expressing RANKL
. Multinucleated giant cells expressing RANK
. Mononuclear stromal cells expressing RANKL
. Mononuclear stromal cells expressing RANK
. Osteoblasts expressing OPG

Correct Answer & Explanation

. Mononuclear stromal cells expressing RANKL


Explanation

In a Giant Cell Tumor of bone (GCT), the true neoplastic cells are the spindle-shaped mononuclear stromal cells. These cells express RANK Ligand (RANKL), which stimulates the recruitment and differentiation of osteoclast-like multinucleated giant cells (which express RANK). Denosumab, a monoclonal antibody against RANKL, is used to treat unresectable GCTs.

Question 867

Topic: Biology, Genetics & Bone Healing

According to Perren's strain theory of bone healing, primary bone healing (direct remodeling without callus) will only occur if the interfragmentary strain is below what threshold?

. 2%
. 5%
. 10%
. 15%
. 20%

Correct Answer & Explanation

. 2%


Explanation

According to Perren's strain theory, absolute stability is required for primary bone healing, which corresponds to an interfragmentary strain of less than 2%. Strains between 2% and 10% tolerate secondary bone healing via callus formation. Strains greater than 10% lead to nonunion as the tissue formed is typically fibrous or granulation tissue.

Question 868

Topic: Biology, Genetics & Bone Healing

According to Perren's strain theory of bone healing, primary (contact) bone healing without callus formation requires the interfragmentary strain to be maintained below what threshold?

. 2%
. 10%
. 20%
. 30%
. 50%

Correct Answer & Explanation

. 10%


Explanation

Perren's strain theory posits that absolute stability is required for primary bone healing, meaning the interfragmentary strain must be maintained below 2%. Secondary bone healing (with callus formation) occurs in environments with relative stability, where strain is between 2% and 10%. Strains above 10% result in nonunion or fibrous tissue formation.

Question 869

Topic: Biology, Genetics & Bone Healing

Denosumab, a monoclonal antibody used in the treatment of recurrent or unresectable Giant Cell Tumor (GCT) of bone, exerts its therapeutic effect by targeting which of the following?

. Vascular endothelial growth factor (VEGF)
. Receptor activator of nuclear factor kappa-B ligand (RANKL)
. Tumor necrosis factor-alpha (TNF-a)
. Osteoprotegerin (OPG)
. Interleukin-1 (IL-1)

Correct Answer & Explanation

. Receptor activator of nuclear factor kappa-B ligand (RANKL)


Explanation

Denosumab is a fully human monoclonal antibody that specifically binds to and inhibits RANKL. By blocking RANKL, denosumab prevents the interaction with RANK receptors on the surface of osteoclast-like giant cells and their precursors, thereby profoundly inhibiting osteoclastogenesis and the severe osteolysis characteristic of GCT.

Question 870

Topic: Biology, Genetics & Bone Healing

A 35-year-old female presents with knee pain. Radiographs reveal an eccentric, lytic, epiphyseal lesion in the distal femur extending to the subchondral bone without a sclerotic border. Biopsy confirms Giant Cell Tumor of bone (GCT). If medical management is considered for a locally advanced and unresectable presentation, which medication specifically targets the pathogenesis of this tumor?

. Imatinib
. Denosumab
. Zoledronic acid
. Methotrexate
. Doxorubicin

Correct Answer & Explanation

. Denosumab


Explanation

Giant Cell Tumor (GCT) of bone features neoplastic stromal cells that express RANKL, which recruits osteoclast-like multinucleated giant cells. Denosumab is a monoclonal antibody that binds to RANKL, potently inhibiting this pathway and is used for advanced or unresectable GCT.

Question 871

Topic: Biology, Genetics & Bone Healing

Bone morphogenetic proteins (BMPs) play a crucial role in osteoinduction by binding to serine/threonine kinase receptors on mesenchymal stem cells. Following receptor activation, which of the following intracellular signaling molecules are directly phosphorylated and translocated to the nucleus to regulate gene transcription for osteoblast differentiation?

. Wnt and Beta-catenin
. NF-kappa B
. Smad 1, 5, and 8
. Mitogen-activated protein (MAP) kinases
. Core-binding factor alpha 1 (Runx2)

Correct Answer & Explanation

. Smad 1, 5, and 8


Explanation

The canonical signaling pathway for bone morphogenetic proteins (BMPs) involves binding to type I and type II serine/threonine kinase receptors. This complex directly phosphorylates receptor-regulated Smads (R-Smads), specifically Smad 1, 5, and 8. The phosphorylated R-Smads then form a complex with the co-Smad (Smad 4) and translocate into the nucleus to activate the transcription of osteogenic genes, including Runx2. Wnt signals via Beta-catenin, and RANKL signals via NF-kappa B.

Question 872

Topic: Biology, Genetics & Bone Healing
Bone morphogenetic proteins (BMPs) play a crucial role in osteoinduction by promoting the differentiation of mesenchymal stem cells into osteoblasts. Which of the following BMPs is commercially available as recombinant human BMP-2 (rhBMP-2) and is FDA-approved for specific applications such as anterior lumbar interbody fusion (ALIF)?
. BMP-3
. BMP-4
. BMP-7
. BMP-2
. BMP-9

Correct Answer & Explanation

. BMP-2


Explanation

Recombinant human BMP-2 (rhBMP-2), also known commercially as INFUSE, is highly osteoinductive and FDA-approved for use in single-level anterior lumbar interbody fusion (ALIF) with a specific LT-CAGE, as well as for certain open tibial shaft fractures and maxillofacial reconstructions. While BMP-7 (OP-1) also has osteoinductive properties and was previously used under a Humanitarian Device Exemption, the product associated with widespread ALIF use is BMP-2.

Question 873

Topic: Biology, Genetics & Bone Healing

Denosumab has revolutionized the medical management of Giant Cell Tumor of bone (GCTB), particularly for unresectable or metastatic lesions. What is the specific molecular mechanism of action of this agent?

. Directly binds and antagonizes the RANK receptor on osteoclasts
. Monoclonal antibody that binds to RANK Ligand (RANKL)
. Acts as a recombinant analog of Osteoprotegerin (OPG)
. Inhibits Vascular Endothelial Growth Factor (VEGF) preventing angiogenesis
. Antagonizes Macrophage colony-stimulating factor (M-CSF)

Correct Answer & Explanation

. Monoclonal antibody that binds to RANK Ligand (RANKL)


Explanation

Denosumab is a fully human monoclonal antibody that specifically binds to the Receptor Activator of Nuclear factor Kappa-B Ligand (RANKL). By neutralizing RANKL produced by the neoplastic stromal cells of a Giant Cell Tumor, it prevents RANKL from binding to the RANK receptor on osteoclast precursors, dramatically arresting the formation and function of the destructive giant osteoclasts.

Question 874

Topic: Biology, Genetics & Bone Healing

According to Perren's strain theory of bone healing, the mechanical environment dictates the type of tissue that forms within a fracture gap. What is the maximum theoretical amount of interfragmentary strain that can be tolerated to permit the formation of primary lamellar bone?

. 2%
. 10%
. 20%
. 30%
. 100%

Correct Answer & Explanation

. 2%


Explanation

Perren's strain theory postulates that a specific tissue can only form if the interfragmentary strain is lower than the strain at which that tissue yields. Lamellar bone can only form under very rigid conditions, tolerating less than 2% strain. Woven bone can form up to 10% strain, cartilage up to 30%, and granulation tissue up to 100%.

Question 875

Topic: Biology, Genetics & Bone Healing

In the process of secondary bone healing, which of the following signaling molecules is a member of the TGF-beta superfamily and acts as a potent osteoinductive factor directly responsible for driving the differentiation of mesenchymal stem cells into osteoblasts?

. Transforming growth factor beta 1 (TGF-b1)
. Vascular endothelial growth factor (VEGF)
. Bone morphogenetic protein-2 (BMP-2)
. Fibroblast growth factor (FGF)
. Interleukin-1 (IL-1)

Correct Answer & Explanation

. Bone morphogenetic protein-2 (BMP-2)


Explanation

Bone morphogenetic proteins (specifically BMP-2, BMP-4, and BMP-7) are key members of the transforming growth factor-beta (TGF-b) superfamily. They are the primary osteoinductive factors responsible for driving the differentiation of undifferentiated mesenchymal stem cells into osteoprogenitor cells and osteoblasts during fracture healing. VEGF is primarily responsible for angiogenesis.

Question 876

Topic: Biology, Genetics & Bone Healing

A 35-year-old female presents with a recurrent giant cell tumor of the distal femur. The multidisciplinary tumor board recommends a trial of denosumab prior to surgical resection. What is the specific mechanism of action of this medication?

. Binds directly to RANK receptors on osteoclasts
. Binds to RANKL, preventing its interaction with RANK
. Inhibits osteoprotegerin (OPG) competitively
. Inhibits matrix metalloproteinases in the tumor microenvironment
. Binds to sclerostin, promoting osteoblast formation

Correct Answer & Explanation

. Binds to RANKL, preventing its interaction with RANK


Explanation

Denosumab is a fully human monoclonal antibody that specifically targets and binds to the Receptor Activator of Nuclear factor Kappa-B Ligand (RANKL). By sequestering RANKL, it prevents RANKL from binding to its receptor (RANK) on the surface of osteoclasts and their precursors, thereby profoundly inhibiting osteoclast formation, function, and survival.

Question 877

Topic: Biology, Genetics & Bone Healing

Bone morphogenetic proteins (BMPs) play a critical role in bone healing. Which of the following statements accurately describes the mechanism of action of BMP-2?

. It acts primarily by inhibiting osteoclast-mediated bone resorption
. It serves as a purely osteoconductive structural scaffold
. It binds to cell-surface receptors to induce mesenchymal stem cells to differentiate into osteoblasts
. It primarily stimulates angiogenesis and endothelial cell proliferation
. It acts extracellularly by cross-linking type I collagen fibers

Correct Answer & Explanation

. It binds to cell-surface receptors to induce mesenchymal stem cells to differentiate into osteoblasts


Explanation

BMP-2 and BMP-7 are potent osteoinductive growth factors. They function by binding to serine/threonine kinase receptors on the surface of undifferentiated mesenchymal stem cells. This binding activates the intracellular Smad signaling pathway, upregulating transcription factors like Runx2, which induces the differentiation of these cells into the osteoblast lineage.

Question 878

Topic: Biology, Genetics & Bone Healing

Which of the following clinical scenarios of bone formation is predominantly driven by intramembranous ossification rather than endochondral ossification?

. Callus formation after closed reduction and casting of a tibial shaft fracture
. Bone lengthening during distraction osteogenesis via an Ilizarov frame
. Longitudinal growth at the physis of the distal femur
. Fracture healing following a hypertrophic nonunion
. Heterotopic ossification following severe head trauma

Correct Answer & Explanation

. Bone lengthening during distraction osteogenesis via an Ilizarov frame


Explanation

Distraction osteogenesis (e.g., bone lengthening via an Ilizarov frame) primarily occurs via intramembranous ossification, where osteoblasts directly differentiate from mesenchymal stem cells to form bone without a cartilage intermediate. Callus formation in secondary fracture healing, physeal growth, and most heterotopic ossification occur via endochondral ossification (forming a cartilage model first).

Question 879

Topic: Biology, Genetics & Bone Healing

Bone Morphogenetic Proteins (BMPs) are used clinically to enhance bone healing. They act as osteoinductive agents by binding to cell surface receptors and initiating an intracellular signaling cascade. Which of the following intracellular signaling molecules is the primary direct mediator of the canonical BMP pathway?

. Beta-catenin
. Smad 1/5/8
. NF-kappaB
. JAK/STAT
. Cyclic AMP

Correct Answer & Explanation

. Smad 1/5/8


Explanation

Bone Morphogenetic Proteins (BMPs) belong to the TGF-beta superfamily. The canonical signaling pathway for BMPs involves binding to serine/threonine kinase cell surface receptors, which then phosphorylate intracellular receptor-regulated Smads, specifically Smad 1, 5, and 8. These complex with the co-Smad (Smad 4) and translocate to the nucleus to regulate gene transcription for osteoblastic differentiation. Beta-catenin is involved in the Wnt signaling pathway. NF-kappaB is involved in RANKL/osteoclast signaling.

Question 880

Topic: Biology, Genetics & Bone Healing

During secondary bone healing, which factor is most crucial for the transition from a soft cartilaginous callus to a hard bony callus?

. Increased motion at the fracture site
. Decreased oxygen tension
. Angiogenesis and vascular ingrowth
. High levels of sclerostin
. Apoptosis of osteoblasts

Correct Answer & Explanation

. Angiogenesis and vascular ingrowth


Explanation

The transition from soft (cartilaginous) callus to hard (bony) callus during endochondral ossification requires adequate vascular ingrowth (angiogenesis), which brings in chondroclasts, osteoprogenitor cells, and oxygen required for matrix mineralization.